chrisvoncsefalvay/vaers-outcomes huggingface dataset:
What the patient wrote below. "However I had a bad reaction to the 2nd covid shot. I woke up with a big lump in my arm. And a bad headache. And I felt nauseous. So bad I had to go to the emergency room and get a shot I feel better much better now. Thank you." Called the patient today and she is fine now and she is completely ok and she is happy now.
Hot to touch, slight swelling about a quarter in size around injection area, low grade fever for approx. 24 hours
Client states itchy large raised blotch to right arm, newly noticed 5 days after receiving vaccines.  Area about 3" circular area red with smaller blotches surrounding.  Advised to try Bendryl OTC topical and oral at bedtime.  To go to doctor if condition worsens or does not improve by AM.
After the first vaccine 3 weeks prior to this I had chest pains 3 days later but attributed it to anything else. The night of the second vaccine shot I had severe chest pains (which I later discovered was gall bladder attack). the morning after I woke up with a fever of 102.9 which maintained for 4 days along with accompanying symptoms, then a delayed allergic reaction started on day 5. I had hives and redness on arm. Took benadryl and called doctor, and was told by doctor to take zyrtec for a week. Approximately 3 weeks after the 4th shot I had the 3rd incidence of chest pains and went to ER. Turned out to be  a gall bladder attack and the first two attacks were as well, had never had an issue prior to covid shots. So with the delayed allergic reaction, multiple days of high fevers and gall bladder removal I figured I should report it.
10 hrs p/vax had tonic clonic jerking w/face grimacing x 3 hrs; then staring & wouldn't recognize mom for 30 mins; fever next day but not @ time of sz;
I have been experiencing severe pain in my joints,  my shoulders and lower back are the worse. It's bad enough I can't sleep very well or even walk right.
pt recv vax 4OCT96 & 1wk post inj 11OCT96, 2wk post inj devel focal skin rash;A biopsy of the rash was performed;later devel numbness of both hands;MRI was done 24OCT96;pt did not exp any motor weakness;rash is subsiding;other sx persist;
Headache, Arthralgia, NauseaVomiting, chills, cramps, sore throat, cough Narrative:  Other Relevant History:
About 2-3 hours after getting Pneumovax23, she noted pain and tenderness in her shoulder which she didn't think was overall concerning.  Overnight, pain spread to her chest and back, and she feels like her who chest is swollen. She couldn't move her arm at all this morning, but she is slowly gaining more movement in her arm. She has never had side effects to vaccines before. No fevers, SOB, nausea, vomiting, diarrhea.
upon  admistering vaccine patient push my hand and syringe away  as soon as he felt the poke
pt stated that she developed hives on her torso and both legs down to the knees and slight headache after taking the covid.  Pt states her symptoms are improving.
vaccine was not diluted. 24 hours later, spoke to mom and patient had no reactions to vaccine
Vaccinated in the beginning but did not get the Boosters on time and came down with COVID; Vaccinated in the beginning but did not get the Boosters on time and came down with COVID; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "Vaccinated in the beginning but did not get the Boosters on time and came down with COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Vaccinated in the beginning but did not get the Boosters on time and came down with COVID; negative, notes: her and her son were negative.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Employee reports pain and decrease in mobility in Left arm and shoulder. Pain is intermittent and increases when raising arm over head. Pain is 8 on 0-10 scale. Takes Aleeve 4 tabs per day.
Within minutes after administration of vaccine, right leg became red. Very shortly after that, redness faded and macular rash appeared. Patient was slightly wheezy. Taken to ER for evaluation and treatment. Received Benadryl, Prelone and albuterol neb treatment X 1. On discharge, no redness or shortness of breath noted, patient alert and playful.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (still has fever in it), VACCINATION SITE MASS (knot at injection site), VACCINATION SITE PAIN (pain at injection site) and VACCINATION SITE ERYTHEMA (bright red area to injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced VACCINATION SITE WARMTH (still has fever in it), VACCINATION SITE MASS (knot at injection site), VACCINATION SITE PAIN (pain at injection site) and VACCINATION SITE ERYTHEMA (bright red area to injection site). At the time of the report, VACCINATION SITE WARMTH (still has fever in it), VACCINATION SITE MASS (knot at injection site), VACCINATION SITE PAIN (pain at injection site) and VACCINATION SITE ERYTHEMA (bright red area to injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I had vertigo and my ENT prescribed meclizine which helped the symptoms and they were gone after 2 days
I went ahead last Monday and got my first COVID-19 Vaccine shot due to the mandate.   Monday / Monday night after the shot I felt fine. Tuesday morning I could not lift my right arm and had a sore throat / Tuesday night by 6pm I had fever, chills and body aches. Wednesday morning I still could not lift my right arm and was nauseous / Wednesday night I was vomiting through the night and had severe head pain which lasted 2 days Thursday along with the head pain I was nauseous through Friday and arm was still sore but able to lift it. I had COVID in January and this was very similar to how I felt when I had COVID.
A patient was administered a dose from a vial that had been open for 22 h; A patient was administered a dose from a vial that had been open for 22 h; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient was administered a dose from a vial that had been open for 22 h) and PRODUCT STORAGE ERROR (A patient was administered a dose from a vial that had been open for 22 h) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033K21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2022 at 3:30 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 14-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient was administered a dose from a vial that had been open for 22 h). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (A patient was administered a dose from a vial that had been open for 22 h). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A patient was administered a dose from a vial that had been open for 22 h) and PRODUCT STORAGE ERROR (A patient was administered a dose from a vial that had been open for 22 h) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. Treatment medications were not provided.  It was reported that patient received booster dose. It was reported that the vial went from the freezer to thawing process at room temperature on13-Apr-2022 at 05:00 pm, (thawing process 2 h) and was first punctured at 13-Apr-2022 at 07:00 pm.  No temperature excursion occurred and vials were stored in room temperature for 22 hours.  The expiry date of the vial was reported as 20-May-2022.
Day after injection reported nausea, cramps in lower extremities, chills and headache; instructed to contact PCP and reported symptoms to v-safe.
Patient received vaccine. After about 3 minutes patient's face became very pale. Medical assistant asked patient if she was feeling okay. Patient reported feeling like she was going to "throw up". Emesis bag, water and apple juice were offered to patient. Staff offered for patient to lay down on exam table. Pt declined, stating she wanted to lay down on floor.  Light in room were turned off as patient reported feeling like lights were too bright.  Pt laid down on the floor for about 7 minutes and states she was feeling better. Pt was able to sit up on chair. Pt drunk apple juice and water. Blood pressure was checked.  Patient was monitored for an additional 7 minutes.  Pt reported feeling well and was discharged with mom.
Fever of 101 redness at the injection site.  She came in today and her arm is red, itching, and hot to the touch.
Local reaction - 15 x 15cm erythema and induration covering most of anterior thigh on left.
ASSOCIATE HAD A FINGER STICK AFTER VACCINATING A PATIENT.  ASSOCIATE WAS TRYING TO ENGAGE SAFETY COVER OVER USED NEEDLE
Received vaccine 10-3-16. 10-4-16 AM - Blisters x 1 and swelling, redness, induration, hot to touch. Later on that day C/O (R) neck stiffness extending to (R) ear.
Area of redness with local temp increased 3 cm x 2 cm R upper arm where MENACTRA was given.
Initial and follow up information has been received from a registered nurse concerning a 19 year old female who on 09-JUL-2007 was vaccinated IM (site not reported) with a first 0.5ml dose of the GARDASIL (lot# 657736/0389U).  The patient was not pregnant at the time of the 1st dose of the GARDASIL.  The patient missed her second dose of the GARDASIL.  The nurse contacted the patient in November 2007, to let her know she needed to come in for her second dose but the she never came.  In December 2007 the patient called the office and said she needed to be seen for pregnancy.  Last menstrual period listed in the office chart was "September or October 2007."  On 12-DEC-2007 the patient called the office with bleeding.  On 13-DEC-2008 the patient had a spontaneous abortion.  The nurse reported that the patient has not resumed the series even though they had attempted many times to contact her.  Upon internal review the spontaneous abortion was determined to be an other important medical event.  Additional information has been requested.
Received doses 2 week after expiration; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received doses 2 week after expiration) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received doses 2 week after expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received doses 2 week after expiration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided.  It was reported that the health care professional (HCP) noted in the records that there are patients who received doses 2 week after expiration. No further information was provided.
Information has been received from a registered nurse concerning a 16 year old female who on 03-JAN-2007 was vaccinated with Gardasil (lot # not reported). On 11-FEB-2007, the patient experienced neck pain, and headache. Medical attention was sought. The patient was hospitalized. The patient had an "eosinophil type reaction" also. Laboratory evaluation revealed elevated eosinophils. The outcome of the neck pain, headache, and eosinophil type reaction was snot reported. No further information was available at the time of reporting. Additional information has been requested.
Rash on both arms. Still persisting 3 months post injection. Menstrual cycle has also been off.
aunt devel varicella 5 days post exposure to child who recv vax;had no other contact;
"Hives, itching" 1 hour after immunizations. Gave Benadryl at home, returned to office - urticaria - Orapred 15mg, Benadryl.
Rash (red, itchy, fine macular popular) around Hep A injection site immediately.  (6 cm diameter).
I first developed  a rash on my leg after two days of 1st dose. The rash became sensitive and hurt to the touch. The right side of my torso and leg were sensitive and painful to the touch. The rash spread down my right leg and was painful to the touch. My leg joins were painful and inflamed (it hurt to lift my thigh leg). I had difficulty walking because the pain in my thigh joint was very painful. It throbbed painfully for three days the following week after the first dose. My knee felt inflamed on the inside, as did my ankle. After three weeks, the pain started to subside. Only now, my leg and nerves seem to be getting better. My skin feels like it would if I was coming out of anesthesia on my leg.
There have been no adverse reactions as far as we no.  The patient received to flucelvax doses.  One on October 24th and another on December 8th. the lot number for the 2nd flucelvax dose she received is AS1596C. She didn't realize she was only suppose to receive 1 flu shot per year.
erythemic rash on torso, legs & arms; pos pain/itch; fever 104.4;
Slight side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Slight side effects) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A, D1DF21A and 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Muscle disorder NOS (Immunocompromised due to Underlying Muscle disease) and Immunocompromised.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Slight side effects). At the time of the report, VACCINATION COMPLICATION (Slight side effects) outcome was unknown.            No concomitant medications were mentioned since patient declined. No treatment details were reported since patient declined.  Patient reported that he is considered immunocompromised as per his doctor due to underlying muscle disease.   This case was linked to MOD-2021-361341, MOD-2021-361352 (Patient Link).
tachycardia, SOB, chills x 7 minutes. Pt given water and snack and recovered. Pt refused EMS transport to emergency department.
Adenopathy supra clavicular on the left side of her neck (same side as the vaccine arm) about; Scratchy Throat; Mild Swelling of Upper Lip; Numbness in the lips,; High Blood Pressure; Pain in the Left Side of the Neck; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL DISCOMFORT (Scratchy Throat), LIP SWELLING (Mild Swelling of Upper Lip), HYPOAESTHESIA ORAL (Numbness in the lips,), BLOOD PRESSURE INCREASED (High Blood Pressure) and NECK PAIN (Pain in the Left Side of the Neck) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced OROPHARYNGEAL DISCOMFORT (Scratchy Throat), LIP SWELLING (Mild Swelling of Upper Lip), HYPOAESTHESIA ORAL (Numbness in the lips,), BLOOD PRESSURE INCREASED (High Blood Pressure) and NECK PAIN (Pain in the Left Side of the Neck). On 09-Jan-2021, the patient experienced LYMPHADENOPATHY (Adenopathy supra clavicular on the left side of her neck (same side as the vaccine arm) about). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. On 28-Dec-2020, OROPHARYNGEAL DISCOMFORT (Scratchy Throat), LIP SWELLING (Mild Swelling of Upper Lip), HYPOAESTHESIA ORAL (Numbness in the lips,), BLOOD PRESSURE INCREASED (High Blood Pressure) and NECK PAIN (Pain in the Left Side of the Neck) had resolved. On 10-Jan-2021, LYMPHADENOPATHY (Adenopathy supra clavicular on the left side of her neck (same side as the vaccine arm) about) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Dec-2021, Blood pressure measurement: (High) 180/100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment include Benadryl injection. No concomitants were provided.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2 (BNT162B2), on 20Dec2021 at 19:00 as dose 3 (booster), single (Lot number: 33033BD) at the age of 55 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Tetracycline, reaction(s): "known allergy: tetracycline"; Dexamethasone, reaction(s): "known allergy:dexamethasone"; Clindamycin, reaction(s): "known allergy:clindamycin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Information: The patient received vaccine. The patient did not received any other medication in 2 weeks. The patient took anti-viral for COVID-19 treatment brand=Paxlovid, treatment start date=20May2022, treatment stop date=24May2022,and lot number=GA2268. Adverse event: When retired to bed, bright flash of light occurs (like when lightening occurs in nature at night) that wakes the patient up at least 4-5 times a night, only to find that there is no lightening or flash. This began the day the patient started Paxlovid. Have reported to PCP. Adverse event start date: 20May2022. Adverse event start time: 23:00 . If patient recovered: Not recovered. If treatment ae: Unknown  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a 88 year old female patient. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On an unknown date in 2003, the patient was vaccinated with ZOSTAVAX for prophylaxis (strength, dose, route, lot # and expiration date were not reported). Since an unknown date in 2015, the patient started to experience a nerve pain in her hands. Then, on an unknown date in 2017, the patient started having pain in her arms at night time. The patient sought medical attention and received an unspecified treatment for the adverse experiences. At the reporting time, the patient was not recovered from neuralgia and pain in extremity. The causality assessment between the events and vaccination with ZOSTAVAX was not provided.
Information has been received from a registered nurse (R.N.) concerning a 25 year old white female licensed practical nurse (L.P.N.) with no medical history and no allergies who on 11/16/2005, at 10:00 am (previously reported as 11/17/2005) was splashed in the eye with a droplet of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot # 647646/0990P). a droplet splashed in her eye when the luer lock syringe was not tightened completely. Unspecified medical attention was sought and no laboratory or diagnostic test were performed. Initial burning sensation of eye noted, flushed with water, and burning subsided and redness noted. The nurse hand been previously vaccinated with two doses of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. It was reported that the LPN had no visual problems or complaints one hour post incident. At the time of reporting she was recovered. No product quality complaint was involved. Additional information has been requested.
PYREXIA  Information has been received from a registered nurse concerning a 12 month old black female with on known drug allergies who on 11-AUG-200 was vaccinated with a first dose of measles virus vaccine live (Enders-Edmonston) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (lot# 652332/1122R). On 11-AUG-2006 the patient developed a fever. On 15-AUG-2006 the patient recovered. Additional information is not expected.
Was like "Arthus"; little swollen, warm, red, had fever that came down. Feeling better.
Approximately 3:58 PM and approximatly after 2 minutes from recieving the vaccine, was walking to Observation area when pt had a near syncopy episode without loss of consciousness or fall.  Pt up, ass essment was AA & Ox4, airway patent, brething non-labored.   Pt was given 1000 ml of water orally over 30 minutes with resolving of low blood pressure.  At 1620 BP: 80/60. At 1700 BP: 118/80.
Pt. has been experiencing pain and tenderness in her left arm since receiving her influenza vaccine. Pt. described the pain as being like bursitis.